The board of directors of Extrawell Pharmaceutical Holdings Limited announced that the company's head office and principal place of business in Hong Kong will be changed to Suites 2206-08, 22nd Floor, Devon House, Taikoo Place, 979 King's Road, Quarry Bay, Hong Kong with effect from 27 January, 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.041 HKD | 0.00% |
|
+5.13% | +20.59% |
28/06 | Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
25/06 | Extrawell Pharmaceutical Warns of Swing to Loss in Fiscal Year 2024 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.59% | 12.55M | |
+55.35% | 848B | |
+31.64% | 627B | |
-0.10% | 363B | |
+15.47% | 318B | |
+13.10% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.54% | 179B | |
+4.31% | 167B |
- Stock Market
- Equities
- 858 Stock
- News Extrawell Pharmaceutical Holdings Limited
- Extrawell Pharmaceutical Holdings Limited Announces Change of Head Office and Principal Place of Business